PHVS
USDPharvaris N.V. Ordinary Shares
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$22.482
Haut
$22.482
Bas
$21.585
Volume
0.14M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.4B
Industrie
Biotechnologie
Pays
Switzerland
Statistiques de Trading
Volume Moyen
0.19M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
ZUG, Switzerland, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living
HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60
HC Wainwright & Co. analyst Patrick R. Trucchio initiates coverage on Pharvaris with a Buy rating and announces Price Target of $60.
B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27
B of A Securities analyst Tazeen Ahmad upgrades Pharvaris from Underperform to Neutral and raises the price target from $16 to $27.
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.